NYSE:FMS

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News

$21.54

-0.12 (-0.55%)

(As of 09/29/2023 ET)

Compare

Today's Range: $21.52
▼
$21.82
50-Day Range: $21.31
▼
$26.61
52-Week Range: $12.78
▼
$27.72

Volume: 448,965 shs
Average Volume: 382,863 shs
Market Capitalization: $12.64 billion

P/E Ratio: 20.51
Dividend Yield: 1.95%
Price Target: $30.98

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating: Reduce
1.90 Rating Score
Upside/Downside: 43.8% Upside
$30.98 Price Target
Short Interest: Healthy
0.18% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.74
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 23.26%
From $1.29 to $1.59 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

91st out of 972 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 7 stocks

3.0

Analyst's Opinion

Consensus Rating
Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on 1 buy rating, 7 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $30.98, Fresenius Medical Care AG & Co. KGaA has a forecasted upside of 43.8% from its current price of $21.54.
Amount of Analyst Coverage
Fresenius Medical Care AG & Co. KGaA has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.18% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.
Short Interest Ratio / Days to Cover
Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 24.57%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 1.93%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 26.42% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FMS.

2.6

News and Social Media Coverage

News Sentiment
Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.
MarketBeat Follows
3 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 5.81% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.

3.8

Earnings and Valuation

Earnings Growth
Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 23.26% in the coming year, from $1.29 to $1.59 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 20.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.98.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 20.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 101.50.
Price to Book Value per Share Ratio
Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS Price History

30 days | 90 days | 365 days | Advanced Chart

FMS Stock News Headlines

October 1, 2023 | americanbankingnews.com

Critical Analysis: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) versus BioRestorative Therapies (NASDAQ:BRTX)

September 27, 2023 | americanbankingnews.com

Financial Survey: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) vs. BioRestorative Therapies (NASDAQ:BRTX)

October 1, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

September 22, 2023 | americanbankingnews.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Recommendation of "Reduce" from Analysts

September 21, 2023 | americanbankingnews.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Downgraded by StockNews.com to "Buy"

September 15, 2023 | finance.yahoo.com

Here's Why You Should Retain Fresenius Medical (FMS) for Now

August 31, 2023 | msn.com

Fresenius Medical Care AG & Co. KGaA - ADR (FMS) Price Target Increased by 7.48% to 24.47

August 24, 2023 | finance.yahoo.com

Fresenius Medical's (FMS) New HHD Device to Increase Portability

October 1, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

August 15, 2023 | msn.com

Fresenius Medical Care falls after UBS downgrades on high consensus estimates

August 3, 2023 | msn.com

Fresenius Medical (FMS) Q2 Earnings and Revenues Beat Estimates

August 2, 2023 | markets.businessinsider.com

Fresenius Q2 EBIT Before Special Items Declines

August 1, 2023 | markets.businessinsider.com

What Wall Street expects from Fresenius Medical Care (FMC) (ADRS)'s earnings

July 13, 2023 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

July 11, 2023 | seekingalpha.com

Martin Fischer to assume CFO post at Fresenius Medical Care in October

June 27, 2023 | seekingalpha.com

DaVita, Fresenius fall on 2024 Medicare rates for dialysis

June 10, 2023 | finance.yahoo.com

Some Investors May Be Worried About Fresenius Medical Care KGaA's (ETR:FME) Returns On Capital

June 7, 2023 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care Aiming for Margin Improvement

June 1, 2023 | msn.com

Fresenius Medical Care: Other Stocks Still Better, But Upside Exists

May 16, 2023 | insidermonkey.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2023 Earnings Call Transcript

May 10, 2023 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care Earnings: Good Start to Year as External Pressures Ease

May 9, 2023 | reuters.com

Fresenius Medical Care's operating profit down 9%

April 19, 2023 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care: 2025 Margin Aspirations Depend on Medtech Segment

March 22, 2023 | finance.yahoo.com

Innovative Home Dialysis Training Unit Opens at Indianapolis Fresenius Kidney Care Location

March 21, 2023 | seekingalpha.com

Fresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' Rating

March 6, 2023 | finance.yahoo.com

Fresenius Kidney Care Renews Commitment to Kidney Health Education with Second Year Boys & Girls Clubs of America National Partnership

February 24, 2023 | finance.yahoo.com

Earnings Update: Fresenius Medical Care AG & Co. KGaA (ETR:FME) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

See More Headlines

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings: 8/02/2023
Today: 10/01/2023
Next Earnings (Estimated): 10/30/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:FMS
CUSIP: N/A
CIK: 1333141
Web: www.freseniusmedicalcare.com
Phone: (496) 172-6090
Fax: 49-6172-609-2301
Employees: 1,235
Year Founded: 1912

Price Target and Rating

Average Stock Price Forecast: $30.98
High Stock Price Forecast: $44.00
Low Stock Price Forecast: $11.70
Forecasted Upside/Downside: +43.8%
Consensus Rating: Reduce
Rating Score (0-4): 1.90
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.05
Trailing P/E Ratio: 20.51
Forward P/E Ratio: 16.70
P/E Growth: N/A
Net Income: $709.50 million
Net Margins: 3.01%
Pretax Margin: 5.74%
Return on Equity: 5.15%
Return on Assets: 2.22%

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.26
Quick Ratio: 0.91

Sales & Book Value

Annual Sales: $20.44 billion
Price / Sales: 0.62
Cash Flow: $4.94 per share
Price / Cash Flow: 4.36
Book Value: $27.74 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 586,830,000
Free Float: N/A
Market Cap: $12.64 billion
Optionable: Optionable
Beta: 1.06

Social Links

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Ms. Helen Giza (Age 55)
CEO, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG
Comp: $3.45M

Dr. Franklin W. Maddux F.A.C.P. (Age 66)
Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
Comp: $2.59M

Mr. William J. Valle (Age 63)
Management Board Member for Care Delivery of Fresenius Medical Care Management AG
Comp: $4.22M

Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 60)
Management Board Member for Care Enablement of Fresenius Medical Care Management AG
Comp: $2.51M

Mr. Roberto Fuste (Age 71)
Exec. Advisor for Regional Strategy

Dr. Dominik Heger
Exec. VP and Head of Investor Relations, Strategic Devel. & Communications

Mr. Borries Von Muller (Age 62)
Sr. VP of Global HR Employee Communications

Mr. Joachim Weith
Sr. VP of Corp. Communications & Gov.al Affairs

Mr. Oliver Maier
Sr. VP Investor Relations

Dr. Gail-Suzanne Brown
Sr. VP of R&D

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" FMS shares.
View FMS analyst ratings or view top-rated stocks.
What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?: 10 brokers have issued 1-year price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $44.00. On average, they expect the company's stock price to reach $30.98 in the next year. This suggests a possible upside of 43.8% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.
How have FMS shares performed in 2023?: Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 at the start of the year. Since then, FMS stock has increased by 31.8% and is now trading at $21.54.
View the best growth stocks for 2023 here.
Are investors shorting Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,080,000 shares, an increase of 24.6% from the August 31st total of 867,000 shares. Based on an average daily volume of 411,900 shares, the days-to-cover ratio is presently 2.6 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.
When is Fresenius Medical Care AG & Co. KGaA's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our FMS earnings forecast.
How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its earnings results on Wednesday, August, 2nd. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.24 by $0.08. The company had revenue of $5.25 billion for the quarter, compared to analyst estimates of $5.19 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.01% and a trailing twelve-month return on equity of 5.15%.
How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Wednesday, May 3rd. Shareholders of record on Thursday, May 18th will be given a dividend of $0.7086 per share on Thursday, June 1st. This represents a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, May 17th.
Read our dividend analysis for FMS.
What ETFs hold Fresenius Medical Care AG & Co. KGaA's stock?: ETFs with the largest weight of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock in their portfolio include Invesco International Dividend Achievers ETF (PID).Cultivar ETF (CVAR).

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.93%. The dividend payout ratio is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 26.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.
What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).
What is Fresenius Medical Care AG & Co. KGaA's stock symbol?: Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."
How do I buy shares of Fresenius Medical Care AG & Co. KGaA?: Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Fresenius Medical Care AG & Co. KGaA's stock price today?: One share of FMS stock can currently be purchased for approximately $21.54.
How much money does Fresenius Medical Care AG & Co. KGaA make?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $12.64 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.05 on an earnings per share basis.
How many employees does Fresenius Medical Care AG & Co. KGaA have?: The company employs 1,235 workers across the globe.
Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?: The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial